Related Experiment Video
Updated: Jan 23, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells
Disheet Shah1, Laura Virtanen2,3, Chandra Prajapati4
1BioMediTech, Faculty of Medicine and Health Technology; Tampere University, 33520 Tampere, Finland. Disheet.shah@tuni.fi.
Insights
This study models dilated cardiomyopathy (DCM) using patient-derived stem cells. Mutant heart cells show stress sensitivity and arrhythmias, providing insights into disease mechanisms.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Genetics
Background:
- Dilated cardiomyopathy (DCM) is a major cause of heart failure and transplantation.
- Familial DCM can result from mutations in the LMNA gene, leading to poor patient prognosis.
- LMNA mutations affect nuclear lamina proteins lamin A and C.
Purpose of the Study:
- To develop a human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) model for LMNA-related DCM.
- To investigate the pathobiology of DCM caused by the p.S143P LMNA mutation.
- To analyze cellular structure, function, and gene/protein expression in mutant hiPSC-CMs.
Main Methods:
- Reprogramming skin fibroblasts from DCM patients with the p.S143P LMNA mutation into hiPSCs.
- Differentiating hiPSCs into cardiomyocytes (CMs).
- Assessing cellular structure, electrophysiology, Ca2+ dynamics, and stress response (hypoxia).
Main Results:
- Mutant hiPSC-CMs exhibited normal sarcomere structure under normoxia but showed damage after hypoxia.
- Electrophysiological evaluation revealed bradyarrhythmia and increased arrhythmias upon beta-adrenergic stimulation.
- Mutant hiPSC-CMs displayed heightened sensitivity to hypoxia and altered calcium handling.
Conclusions:
- The p.S143P hiPSC-CM model effectively mimics key features of LMNA-related DCM.
- This model serves as a valuable tool for studying the cellular mechanisms driving cardiac degeneration in this disease.
- Findings highlight the impact of LMNA mutations on cardiomyocyte structure, function, and stress response.
Abstract:
Dilated cardiomyopathy (DCM) is one of the leading causes of heart failure and heart transplantation. A portion of familial DCM is due to mutations in the LMNA gene encoding the nuclear lamina proteins lamin A and C and without adequate treatment these patients have a poor prognosis. To get better insights into pathobiology behind this disease, we focused on modeling LMNA-related DCM using human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM). Primary skin fibroblasts from DCM patients carrying the most prevalent Finnish founder mutation (p.S143P) in LMNA were reprogrammed into hiPSCs and further differentiated into cardiomyocytes (CMs). The cellular structure, functionality as well as gene and protein expression were assessed in detail. While mutant hiPSC-CMs presented virtually normal sarcomere structure under normoxia, dramatic sarcomere damage and an increased sensitivity to cellular stress was observed after hypoxia. A detailed electrophysiological evaluation revealed bradyarrhythmia and increased occurrence of arrhythmias in mutant hiPSC-CMs on β-adrenergic stimulation. Mutant hiPSC-CMs also showed increased sensitivity to hypoxia on microelectrode array and altered Ca2+ dynamics. Taken together, p.S143P hiPSC-CM model mimics hallmarks of LMNA-related DCM and provides a useful tool to study the underlying cellular mechanisms of accelerated cardiac degeneration in this disease.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Cardiomyopathy II: Dilated Cardiomyopathy
Embryonic Stem Cells
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

